[HTML][HTML] Real-world COVID-19 vaccine effectiveness against the Omicron BA. 2 variant in a SARS-CoV-2 infection-naive population
…, A Hachim, LCH Tsang, KWH Yam, S Chaothai… - Nature medicine, 2023 - nature.com
The SARS-CoV-2 Omicron variant has demonstrated enhanced transmissibility and escape
of vaccine-derived immunity. Although first-generation vaccines remain effective against …
of vaccine-derived immunity. Although first-generation vaccines remain effective against …
[HTML][HTML] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
…, A Hachim, Y Zhang, SM Chan, S Chaothai… - Nature …, 2022 - nature.com
We present an interim analysis of a registered clinical study (NCT04800133) to establish
immunobridging with various antibody and cellular immunity markers and to compare the …
immunobridging with various antibody and cellular immunity markers and to compare the …
[HTML][HTML] Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection
…, SMS Cheng, RLW Ko, JKC Li, S Chaothai… - …, 2021 - thelancet.com
Background The duration of immunity in SARS-CoV-2 infected people remains unclear.
Neutralizing antibody responses are the best available correlate of protection against re-infection…
Neutralizing antibody responses are the best available correlate of protection against re-infection…
[HTML][HTML] Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and …
…, LLH Luk, LCH Tsang, KKH Kwan, S Chaothai… - The Lancet …, 2023 - thelancet.com
Background Few trials have compared homologous and heterologous third doses of COVID-19
vaccination with inactivated vaccines and mRNA vaccines. The aim of this study was to …
vaccination with inactivated vaccines and mRNA vaccines. The aim of this study was to …
[HTML][HTML] Strength and durability of antibody responses to BNT162b2 and CoronaVac
…, EYC Shiu, AYT Lai, SMS Cheng, S Chaothai… - Vaccine, 2022 - Elsevier
We studied 2780 adults in Hong Kong who received CoronaVac inactivated virus vaccine (Sinovac)
and BNT162b2 mRNA vaccine (“Comirnaty”, BioNTech/Fosun Pharma). We …
and BNT162b2 mRNA vaccine (“Comirnaty”, BioNTech/Fosun Pharma). We …
[HTML][HTML] Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents
…, IYS Tam, JHY Lam, SM Chan, S Chaothai… - Frontiers in …, 2023 - frontiersin.org
Introduction Two doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high
efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be …
efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be …
Immunogenicity of a third dose of BNT162b2 to ancestral severe acute respiratory syndrome coronavirus 2 and the omicron variant in adults who received 2 doses of …
…, YWY Leung, LCH Tsang, S Chaothai… - Clinical Infectious …, 2023 - academic.oup.com
Background Limited data exist on antibody responses to mixed vaccination strategies that
involve inactivated coronavirus disease 2019 (COVID-19) vaccines, particularly in the context …
involve inactivated coronavirus disease 2019 (COVID-19) vaccines, particularly in the context …
[HTML][HTML] Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
…, HHW Wong, AMT Lee, WY Li, S Chaothai… - Frontiers in …, 2022 - frontiersin.org
Our study (NCT04800133) aimed to determine the safety and immunogenicity in patients
with IEIs receiving a 3-dose primary series of mRNA vaccine BNT162b2 (age 12+) or …
with IEIs receiving a 3-dose primary series of mRNA vaccine BNT162b2 (age 12+) or …
[HTML][HTML] Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
…, KCK Chan, JKC Li, LLH Luk, S Chaothai… - … and Targeted Therapy, 2022 - nature.com
The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron
BA.1 has been reported in some studies, but immune responses conferring this protection …
BA.1 has been reported in some studies, but immune responses conferring this protection …
Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine
…, JKC Li, YWY Leung, LCH Tsang, S Chaothai… - medRxiv, 2022 - medrxiv.org
Background Limited data exist on antibody responses to mixed vaccination strategies involving
inactivated COVID-19 vaccines, particularly in the context of emerging variants. Methods …
inactivated COVID-19 vaccines, particularly in the context of emerging variants. Methods …